KCNIP3 and amyotrophic lateral sclerosis: Supporting these results, recent genome-wide gene-set analysis experiments performed in the European descent ALS-control cohort of 9244 ALS cases compared to 12,795 healthy controls confirmed a DREAM dysregulation in ALS pathophysiology [58].